Banner Image

 

Twitter icon LinkedIn icon
Gray Chevron

About Medical Publishing Insights & Practices (MPIP)


Medical Publishing Insights & Practices (MPIP) was founded by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP) to elevate trust, transparency, and integrity in reporting the results of industry-sponsored research. Current corporate co-sponsors include Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Research & Development LLC, Merck, Pfizer, and Takeda.

MPIP encourages more effective partnership between sponsors and journals to raise standards in medical publications and expand access to research results. Editors of worldwide biomedical journals have participated in MPIP activities, including representatives of Annals of Internal Medicine, Blood, BMJ, Canadian Medical Association Journal, European Respiratory Journal, Journal of the American Medical Association, Journal of Clinical Oncology, Journal of the American College of Cardiology, Nature Medicine, Neurology, The New England Journal of Medicine, and The Lancet.

MPIP Accomplishments


Through independent research, industry–journal roundtables, and multidisciplinary collaboration, we have enhanced the understanding of issues and challenges in reporting the results of industry-sponsored research and developed tools to improve transparency and credibility. Our research results are disseminated through publications, education, and society meetings such as the Council for Science Editors (CSE), ISMPP, International Congress on Peer Review and Biomedical Publication, and the International Publication Planning Association (TIPPA), as well as through webcasts and webinars.

MPIP Members


Amgen AstraZeneca Biogen Bristol-Meyers Squibb GlaxoSmithKline
ISMPP Janssen MERCK Pfizer Takeda

MPIP Funding


Medical Publishing Insights & Practices (MPIP) is funded equally by the following co-sponsors: Amgen, AstraZeneca, Biogen, Bristol-Myers Squibb, GlaxoSmithKline, Janssen Research & Development LLC, Merck, Pfizer, and Takeda. Each co-sponsor is represented on the MPIP steering committee along with representation from the International Society for Medical Publication Professionals. The MPIP steering committee meets regularly to advance research, educational, and collaborative initiatives aligned with the MPIP mission. For external activities such as Roundtable meetings, all attendees pay their own travel and lodging expenses. MPIP does not pay honoraria to anyone who contributes to any MPIP initiative.

MPIP Major Collaborative Events


  • 2017
  • 8th Journal–Pharma Roundtable

    Philadelphia, USA — Obtained input on author perspectives and discussed ways to improve the author experience when partnering with sponsors and journals to publish their industry-sponsored research.

  • 2016
  • 7th Journal–Pharma Roundtable

    Philadelphia, USA — Obtained input on findings of the Journal Editor Survey and discussed perceived changes in transparency and credibility in reporting industry-sponsored research.

  • 2014
  • 6th Journal–Pharma Roundtable

    Philadelphia, USA — Obtained input on findings of Adverse Event Initiative and developed preliminary recommendations to increase transparency for reporting of these results in manuscripts.

  • 2013
  • 5th Journal–Pharma Roundtable

    Manchester, UK — Obtained input on findings of Authorship Research Initiative and Five-Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Clinical Trial Publications.

  • 2012
  • 4th Journal–Pharma Roundtable

    New York City, USA — Obtained input on findings of Authorship Research Initiative and Five-Step Authorship Framework to Improve Transparency in Disclosing Contributors to Industry-Sponsored Clinical Trial Publications.

  • 2011
  • 3rd Journal–Pharma Roundtable

    New York City, USA — "Deep dive" into unmet needs in authorship, trial protocols, and AE reporting.

  • 2010
  • MPIP Receives Trust & Reputation Award

    MPIP cited as "driving best industry practice and reputation—especially around transparency".

  • 2nd Journal–Pharma Roundtable

    New York City, USA — Identified strategies to "close the credibility gap" in industry-sponsored clinical research.

  • 2009
  • 1st Journal–Pharma Roundtable

    Vancouver, Canada — Brainstormed solutions to streamline manuscript submission in light of increased submission volume.

  • 2008
  • MPIP Founded

    Founded by members of the pharmaceutical industry and the International Society for Medical Publication Professionals (ISMPP).

 

Privacy Policy | Contact Us
Copyright © 2011-2016 MPIP. All Rights Reserved.